MedPath

Assessment of the Effects of Postbiotic Supplementation with Lactobacillus rhamnosus CRL 1505 and Lactobacillus acidophilus (Johnsonii) La1, with a Focus on Interferon-Beta and Interleukin 6 ; Impact on Upper Respiratory Tract Infection Incidence.

Not Applicable
Recruiting
Conditions
The effect of postbiotic supplementation on upper respiratory tract infection with a focus on beta interferon and interleukin 6..
Acute upper respiratory infection, unspecifiedUpper respiratory:disease, acuteinfection NOS
J06.9
Registration Number
IRCT20100119003106N46
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Adult men and women aged between 18 and 65 years who have a thorough comprehension of the potential risks and benefits.
They are required to sign informed consent forms before participating.

Exclusion Criteria

Unwillingness to continue or participate in the study
Diagnosis of immunodeficiency due to any diagnosed chronic disease
Gastrointestinal ulcer
Liver and kidney dysfunction
Human immunodeficiency virus
Autoimmune disorders
Malignancy or any history of malignancy
Any diagnosis of respiratory diseases with cold or flulike symptoms
Severe diseases such as asthma and severe allergies
Pregnancy, breastfeeding
Drug or alcohol addiction
Taking any immunosuppressants or immunomodulators

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath